Abstract
Fragment-based drug discovery (FBDD) has grown into a well-established approach in the pursuit of new therapeutics. Key to the success of FBDD is the low molecular complexity of the initial hits and this has resulted in fragment libraries that mainly contain compounds with a two-dimensional (2D) shape. In an effort to increase the chemical diversity and explore the impact of increased molecular complexity on the hit rate of fragment library screening, several academic and industrial groups have designed and synthesised novel fragments with a three-dimensional (3D) shape. This review provides an overview of 25 synthetic 3D fragment libraries from the recent literature. We calculate and compare physicochemical properties and descriptors that are typically used to measure molecular three-dimensionality such as fraction sp3 (Fsp3), plane of best fit (PBF) scores and principal moment of inertia (PMI) plots. Although the libraries vary widely in structure and properties, some key common features can be identified which may have utility in designing the next generation of 3D fragment libraries.
Original language | English |
---|---|
Pages (from-to) | 77-90 |
Number of pages | 14 |
Journal | Drug Discovery Today: Technologies |
Volume | 38 |
DOIs | |
Publication status | Published - Dec 2020 |
Bibliographical note
Funding Information:We acknowledge funding from the European Union's Framework Programme for Research and Innovation Horizon 2020 (2014?2020) under the Marie-Skoldowska-Curie grant agreement number 675899 (?Fragment based drug discovery Network, FRAGNET?), the Dutch Research Council under Applied and Engineering Sciences grant number?18019(?Ready for growth: a new generation of highly versatile fragment libraries?) and The Royal Society (Industry Fellowship, INFR1191028).
Funding Information:
We acknowledge funding from the European Union’s Framework Programme for Research and Innovation Horizon 2020 (2014–2020) under the Marie-Skoldowska-Curie grant agreement number 675899 (“Fragment based drug discovery Network, FRAGNET”), the Dutch Research Council under Applied and Engineering Sciences grant number 18019 (“Ready for growth: a new generation of highly versatile fragment libraries”) and The Royal Society (Industry Fellowship, INFR1191028 ).
Publisher Copyright:
© 2021
Funding
We acknowledge funding from the European Union's Framework Programme for Research and Innovation Horizon 2020 (2014?2020) under the Marie-Skoldowska-Curie grant agreement number 675899 (?Fragment based drug discovery Network, FRAGNET?), the Dutch Research Council under Applied and Engineering Sciences grant number?18019(?Ready for growth: a new generation of highly versatile fragment libraries?) and The Royal Society (Industry Fellowship, INFR1191028). We acknowledge funding from the European Union’s Framework Programme for Research and Innovation Horizon 2020 (2014–2020) under the Marie-Skoldowska-Curie grant agreement number 675899 (“Fragment based drug discovery Network, FRAGNET”), the Dutch Research Council under Applied and Engineering Sciences grant number 18019 (“Ready for growth: a new generation of highly versatile fragment libraries”) and The Royal Society (Industry Fellowship, INFR1191028 ).
Funders | Funder number |
---|---|
European Union's Framework Programme for Research and Innovation Horizon 2020 | |
Not added | 18019, 053.70.357 |
Royal Society | INFR1191028 |
Horizon 2020 Framework Programme | 675899 |